Hi everyone, I am from Moscow Russia, I am working with chip-seq
-
-
That's pretty cool - where are you getting your reads from?The more you know, the more you know you don't know. —Aristotle -
apfejes, hi!
I am getting reads from IlluminaComment
-
Hi svz,
Thanks for the reply - Actually, I was more curious about which institution in Russia is running the Illumina machines, or if you are sending your samples elsewhere to be run.
Good luck with your experiments!
AnthonyThe more you know, the more you know you don't know. —AristotleComment
-
I understand your scepticism.... but actually, we really have got illumina machine... thank's for wishes!Comment
-
Hi Svz,
Not skepticism at all! I was just curious about who in Russia has an Illumina. Anyhow, you don't need to tell me at all - it was simply curiosity.The more you know, the more you know you don't know. —AristotleComment
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...
Comment